Skip to main content
Healthcare

STAT+: Dutch antitrust regulators probe Biogen over test for its MS drug

STAT+: Dutch antitrust regulators probe Biogen over test for its MS drug

Feed excerpt — reported by STAT News

Dutch anti-trust regulators are investigating allegations that Biogen may have abused its dominant position in the market for MS treatments and associated blood tests.

MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at STAT News →

Original Source

This article was syndicated from STAT News. All rights remain with the original publisher.